Publication | Closed Access
Rugulotrosins A and B: Two New Antibacterial Metabolites from an Australian Isolate of a <i>Penicillium </i>sp.
60
Citations
2
References
2004
Year
Antimicrobial ChemotherapyDrug ResistanceAustralian IsolateAntimicrobial ResistanceHealth SciencesNew Antibacterial MetabolitesAntimicrobial Drug DiscoveryChiral Symmetric DimerAntibacterial AgentRugulotrosin AAntimicrobial CompoundPharmacologyClinical MicrobiologyAntifungal AgentAntibioticsRugulotrosin BMicrobiologyAntimicrobial AgentsMedicine
Two new antibacterial agents, rugulotrosin A (1) and B (2), were obtained from cultures of a Penicillium sp. isolated from soil samples acquired near Sussex Inlet, New South Wales, Australia. Rugulotrosin A (1) is a chiral symmetric dimer, and its relative stereostructure was determined by spectroscopic and X-ray crystallographic analysis. Rugulotrosin B (2) is a chiral asymmetric dimer isomeric with 1. Its structure was determined by spectroscopic analysis with comparison to the co-metabolite 1 and previously reported fungal metabolites. Both rugulotrosins A and B displayed significant antibacterial activity against Bacillus subtilis, while rugulotrosin A was also strongly active against Enterococcus faecalis and B. cereus.
| Year | Citations | |
|---|---|---|
Page 1
Page 1